Diabetologists and Oncologists attitudes towards treating diabetes in the oncologic patient: Insights from an exploratory survey (256 views)
Diabetes Res Clin Pract (ISSN: 0168-8227linking), 2018 Sep; 143: 420-427.
Export to BibTeX Export to EndNote
Paper type: Journal Articles, Review,
Impact factor: 3.639, 5-year impact factor: 3.308
Url: Not available.
Keywords: Antidiabetic Drugs, Clinical Management, Smbg, Survey, Tumors, Type 2 Diabetes Mellitus, Adult , Blood Glucose Self-Monitoring Methods , Type 2 Blood Drug Therapy , Female , Humans , Middle Aged , Neoplasms Complications , Oncologists Standards , Surveys And Questionnaires, Dipeptidyl Peptidase Iv Inhibitor, Glitazone Derivative, Insulin, Metformin, Sulfonylurea, Artificial Feeding, Blood Glucose Monitoring, Cancer Patient, Controlled Study, Counseling, Diabetologist, Diet Restriction, Disease Severity, Exploratory Research, Health Personnel Attitude, Hypoglycemia, Life Expectancy, Prevalence, Prognosis, Review, Terminally Ill Patient, Non Insulin Dependent Diabetes Mellitus, Procedures,
Affiliations:
*** IBB - CNR ***
IRPPS-Institute for Research on Population and Social Policies of the Italian National Research Council, Fisciano, Salerno, Italy. Electronic address: gennaro.clemente@cnr.it.
Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
IBB-Institute of Biostructure and Bioimaging, of the Italian National Research Council, Naples, Italy.
Oncological Endocrinology Unit, Department of Medical Sciences, University of Turin, AOU Citta della Salute e della Scienza di Torino, Turin, Italy.
References:
Handelsman, Y., Leroith, D., Bloomgarden, Z.T., Dagogo-Jack, S., Einhorn, D., Garber, A.J., Grunberger, G., Hennekens, C.H., , pp. 675-93. , http://doi.org/10.4158/EP13248.CS, Diabetes and cancer an AACE/ACE consensus statement. Endocr Pract. 2013 Jul-Aug
Ranc, K., Jørgensen, M.E., Friis, S., Carstensen, B., Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment (2014) Diabetologia, 57, pp. 927-93
Weiser, M.A., Cabanillas, M.E., Konopleva, M., Thomas, D.A., Pierce, S.A., Escalante, C.P., Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen (2004) Cancer, 100 (6), pp. 1179-1185
Lee, W., Yoon, Y.S., Han, H.S., Cho, J.Y., Choi, Y., Jang, J.Y., Prognostic relevance of preoperative diabetes mellitus and the degree of hyperglycemia on the outcomes of resected pancreatic ductal adenocarcinoma (2016) J Surg Oncol, 113 (2), pp. 203-208
Psarakis, H.M., Clinical challenges in caring for patients with diabetes and cancer (2006) Diabetes Spectrum, 19 (3), pp. 157-162
Mateo, J., Castro, F., Olmos, D., (2013), pp. 72-88. , on behalf of the European Society for Medical Oncology. Cancer treatment in patients with diabetes. In 2013 ESMO Handbook on cancer treatment in special clinical situations: Edit. ESMO Press
http://www.uhb.nhs.uk/Downloads/pdf/CancerPbDiabetesMellitus.pdf, Pan Birmingham Cancer Network: Guideline for the Management of Diabetes Mellitus in Palliative Medicine. [accessed August 2017]
Diabetes, U.K., http://www.diabetes.org.uk/upload/Position%20statements/End-of-life-care-Clinical-recs111113.pdf, End of Life Diabetes Care - Clinical Care Recommendations. [accessed August 2017]
Gallo, M., Gentile, L., Arvat, E., Bertetto, O., Clemente, G., Diabetology and oncology meet in a network model: union is strength (2016) Acta Diabetol, 53, pp. 515-524
http://aemmedi.it/diabete-e-tumori/, AMD (Italian Association of Diabetologists) Working Group on “Diabetes and Cancer”. [accessed August 2017]
Poulson, J., The management of diabetes in patients with advanced cancer (1997) J Pain Symptom Manage, 13, pp. 339-346
Jacob, P., Chowdhury, T.A., Management of diabetes in patients with cancer (2015) QJM, 108, pp. 443-448
McCoubrie, R., Jeffrey, D., Paton, C., Dawes, L., Managing diabetes mellitus in patients with advanced cancer: a case note audit and guidelines (2005) Eur J Cancer Care (Engl), 14 (3), pp. 244-248
Quinn, K., Hudson, P., Dunning, T., Diabetes management in patients receiving palliative care (2006) J Pain Symptom Manage, 32, pp. 275-286
Ford-Dunn, S., Smith, A., Quin, J., Management of diabetes during the last days of life: attitudes of consultant diabetologists and consultant palliative care physicians in the UK (2006) Palliat Med, 20 (3), pp. 197-203
Dionisio, R., Giardini, A., De Cata, P., Pirali, B., Rossi, S., Negri, E.M., Diabetes management in end of life: a preliminary report stemming from clinical experience (2015) Am J Hosp Palliat Care, 32 (6), pp. 588-593
Gallo, M., Muscogiuri, G., Felicetti, F., Faggiano, A., Trimarchi, F., Arvat, E., Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes (2018) Metabolism, 78, pp. 141-154
http://www.reteoncologica.it/area-operatori/terapie-di-supporto/raccomandazioni-terapie-di-supporto, Rete Oncologica Piemonte-Valle d'Aosta. Protocollo per la gestione del paziente oncologico con diabete mellitoUR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044727563&doi=10.1016%2fj.diabres.2018.02.044&partnerID=40&md5=c33f361b66075f03843223b61d48d36e
Diabetes Res Clin Pract (ISSN: 0168-8227linking), 2018 Sep; 143: 420-427.
Export to BibTeX Export to EndNote
Paper type: Journal Articles, Review,
Impact factor: 3.639, 5-year impact factor: 3.308
Url: Not available.
Keywords: Antidiabetic Drugs, Clinical Management, Smbg, Survey, Tumors, Type 2 Diabetes Mellitus, Adult , Blood Glucose Self-Monitoring Methods , Type 2 Blood Drug Therapy , Female , Humans , Middle Aged , Neoplasms Complications , Oncologists Standards , Surveys And Questionnaires, Dipeptidyl Peptidase Iv Inhibitor, Glitazone Derivative, Insulin, Metformin, Sulfonylurea, Artificial Feeding, Blood Glucose Monitoring, Cancer Patient, Controlled Study, Counseling, Diabetologist, Diet Restriction, Disease Severity, Exploratory Research, Health Personnel Attitude, Hypoglycemia, Life Expectancy, Prevalence, Prognosis, Review, Terminally Ill Patient, Non Insulin Dependent Diabetes Mellitus, Procedures,
Affiliations:
*** IBB - CNR ***
IRPPS-Institute for Research on Population and Social Policies of the Italian National Research Council, Fisciano, Salerno, Italy. Electronic address: gennaro.clemente@cnr.it.
Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
IBB-Institute of Biostructure and Bioimaging, of the Italian National Research Council, Naples, Italy.
Oncological Endocrinology Unit, Department of Medical Sciences, University of Turin, AOU Citta della Salute e della Scienza di Torino, Turin, Italy.
References:
Handelsman, Y., Leroith, D., Bloomgarden, Z.T., Dagogo-Jack, S., Einhorn, D., Garber, A.J., Grunberger, G., Hennekens, C.H., , pp. 675-93. , http://doi.org/10.4158/EP13248.CS, Diabetes and cancer an AACE/ACE consensus statement. Endocr Pract. 2013 Jul-Aug
Ranc, K., Jørgensen, M.E., Friis, S., Carstensen, B., Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment (2014) Diabetologia, 57, pp. 927-93
Weiser, M.A., Cabanillas, M.E., Konopleva, M., Thomas, D.A., Pierce, S.A., Escalante, C.P., Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen (2004) Cancer, 100 (6), pp. 1179-1185
Lee, W., Yoon, Y.S., Han, H.S., Cho, J.Y., Choi, Y., Jang, J.Y., Prognostic relevance of preoperative diabetes mellitus and the degree of hyperglycemia on the outcomes of resected pancreatic ductal adenocarcinoma (2016) J Surg Oncol, 113 (2), pp. 203-208
Psarakis, H.M., Clinical challenges in caring for patients with diabetes and cancer (2006) Diabetes Spectrum, 19 (3), pp. 157-162
Mateo, J., Castro, F., Olmos, D., (2013), pp. 72-88. , on behalf of the European Society for Medical Oncology. Cancer treatment in patients with diabetes. In 2013 ESMO Handbook on cancer treatment in special clinical situations: Edit. ESMO Press
http://www.uhb.nhs.uk/Downloads/pdf/CancerPbDiabetesMellitus.pdf, Pan Birmingham Cancer Network: Guideline for the Management of Diabetes Mellitus in Palliative Medicine. [accessed August 2017]
Diabetes, U.K., http://www.diabetes.org.uk/upload/Position%20statements/End-of-life-care-Clinical-recs111113.pdf, End of Life Diabetes Care - Clinical Care Recommendations. [accessed August 2017]
Gallo, M., Gentile, L., Arvat, E., Bertetto, O., Clemente, G., Diabetology and oncology meet in a network model: union is strength (2016) Acta Diabetol, 53, pp. 515-524
http://aemmedi.it/diabete-e-tumori/, AMD (Italian Association of Diabetologists) Working Group on “Diabetes and Cancer”. [accessed August 2017]
Poulson, J., The management of diabetes in patients with advanced cancer (1997) J Pain Symptom Manage, 13, pp. 339-346
Jacob, P., Chowdhury, T.A., Management of diabetes in patients with cancer (2015) QJM, 108, pp. 443-448
McCoubrie, R., Jeffrey, D., Paton, C., Dawes, L., Managing diabetes mellitus in patients with advanced cancer: a case note audit and guidelines (2005) Eur J Cancer Care (Engl), 14 (3), pp. 244-248
Quinn, K., Hudson, P., Dunning, T., Diabetes management in patients receiving palliative care (2006) J Pain Symptom Manage, 32, pp. 275-286
Ford-Dunn, S., Smith, A., Quin, J., Management of diabetes during the last days of life: attitudes of consultant diabetologists and consultant palliative care physicians in the UK (2006) Palliat Med, 20 (3), pp. 197-203
Dionisio, R., Giardini, A., De Cata, P., Pirali, B., Rossi, S., Negri, E.M., Diabetes management in end of life: a preliminary report stemming from clinical experience (2015) Am J Hosp Palliat Care, 32 (6), pp. 588-593
Gallo, M., Muscogiuri, G., Felicetti, F., Faggiano, A., Trimarchi, F., Arvat, E., Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes (2018) Metabolism, 78, pp. 141-154
http://www.reteoncologica.it/area-operatori/terapie-di-supporto/raccomandazioni-terapie-di-supporto, Rete Oncologica Piemonte-Valle d'Aosta. Protocollo per la gestione del paziente oncologico con diabete mellitoUR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044727563&doi=10.1016%2fj.diabres.2018.02.044&partnerID=40&md5=c33f361b66075f03843223b61d48d36e
Diabetologists and Oncologists attitudes towards treating diabetes in the oncologic patient: Insights from an exploratory survey
Aims: Diabetes and cancer frequently coexist in the same subject, often having relevant effects on the management and prognosis of the oncologic patient. However, existing guidelines do not deal with many clinical issues in this setting appropriately. In evaluating the opinions of Diabetologists and Oncologists dealing with diabetes care in people with cancer, the Italian Association of Diabetologists (AMD) promoted a dedicated exploratory survey. Methods: The survey was carried out through the web or handily delivered printed copies between October 2014 and April 2015, in Italy. It was composed of 27 questions intended to gather information on the characteristics of participants and to examine their clinical habits in this context, and participation was totally free and anonymous. Results: A total of 252 physicians participated in the survey. Diabetologists accounted for 51.1% of respondents. According to survey results, in spite of the presence of diabetes (or diabetic complications) worsening the outcome of cancer treatments, the counseling or intervention of a Diabetologist was only required for less than two-thirds of hospitalized patients. For subjects with a life expectancy of months, 80% of specialists considered a glycemic target of 120–250 mg/dL optimal whereas Oncologists were more likely to consider a range of 180–360 mg/dL for patients with a shorter life expectancy. Furthermore, 1 participant out of 3 indicated 1–4 measurements/day as the most appropriate frequency for blood glucose monitoring including in the palliative setting. Insulin was the therapy of choice for the majority of respondents albeit with different routes of administration. Conclusions: This survey provides interesting preliminary data that could help facilitate and optimize the management of patients with cancer and diabetes, promoting the delivery of an organic answer to fragmented assistance, to potentially inappropriate behaviors, and to a tailored therapy in a context of particular clinical fragility. © 2018 Elsevier B.V.
Aims: Diabetes and cancer frequently coexist in the same subject, often having relevant effects on the management and prognosis of the oncologic patient. However, existing guidelines do not deal with many clinical issues in this setting appropriately. In evaluating the opinions of Diabetologists and Oncologists dealing with diabetes care in people with cancer, the Italian Association of Diabetologists (AMD) promoted a dedicated exploratory survey. Methods: The survey was carried out through the web or handily delivered printed copies between October 2014 and April 2015, in Italy. It was composed of 27 questions intended to gather information on the characteristics of participants and to examine their clinical habits in this context, and participation was totally free and anonymous. Results: A total of 252 physicians participated in the survey. Diabetologists accounted for 51.1% of respondents. According to survey results, in spite of the presence of diabetes (or diabetic complications) worsening the outcome of cancer treatments, the counseling or intervention of a Diabetologist was only required for less than two-thirds of hospitalized patients. For subjects with a life expectancy of months, 80% of specialists considered a glycemic target of 120–250 mg/dL optimal whereas Oncologists were more likely to consider a range of 180–360 mg/dL for patients with a shorter life expectancy. Furthermore, 1 participant out of 3 indicated 1–4 measurements/day as the most appropriate frequency for blood glucose monitoring including in the palliative setting. Insulin was the therapy of choice for the majority of respondents albeit with different routes of administration. Conclusions: This survey provides interesting preliminary data that could help facilitate and optimize the management of patients with cancer and diabetes, promoting the delivery of an organic answer to fragmented assistance, to potentially inappropriate behaviors, and to a tailored therapy in a context of particular clinical fragility. © 2018 Elsevier B.V.
Diabetologists and Oncologists attitudes towards treating diabetes in the oncologic patient: Insights from an exploratory survey
No results. |
Diabetologists and Oncologists attitudes towards treating diabetes in the oncologic patient: Insights from an exploratory survey
Other filter: ([btitle,keywords] "Antidiabetic Drugs" ...
Tumminia A, Milluzzo A, Cinti F, Parisi M, Tata F, Frasca F, Frittitta L, Vigneri R, Sciacca L
* Abnormal 1-hour post-load glycemia during pregnancy impairs post-partum metabolic status: a single-center experience (171 views)
J Endocrinol Invest (ISSN: 1720-8386, 0391-4097, 1720-8386electronic), 2017 Oct 24; N/D: N/D-N/D.
Impact Factor: 3.166
View Export to BibTeX Export to EndNote
Monti SM, Supuran CT, De Simone G
* DPP-4 inhibitors: a patent review (2012 - 2014) (574 views)
Expert Opin Ther Pat (ISSN: 1354-3776, 1744-7674electronic), 2015 Feb; 25(2): 209-236.
Impact Factor: 4.626
View Export to BibTeX Export to EndNote
Coppo C, Bonfanti D, Bo S, Giordanino C, Gallo M, Cococcia S, Ciccone G, Smedile A, Ciancio A, Bugianesi E, Fagoonee S, Pellicano R, Rizzetto M, Saracco GM
* Risk of microangiopathy in type 2 diabetes mellitus patients with or without chronic hepatitis C: Results of a retrospective long-term controlled cohort study (303 views)
Dig Liver Dis (ISSN: 1590-8658, 1590-8658linking), 2015; 47(5): 405-410.
Impact Factor: 2.719
View Export to BibTeX Export to EndNote
Paladini D, Quarantelli M, Sglavo G, Pastore G, Cavallaro A, D'Armiento MR, Salvatore M, Nappi C
* Accuracy of neurosonography and MRI in clinical management of fetuses referred with central nervous system abnormalities (342 views)
Ultrasound Obst Gyn (ISSN: 0960-7692, 1469-0705), 2014 Aug; 44(2): 188-196.
Impact Factor: 3.853
View Export to BibTeX Export to EndNote
Paladini D, Quarantelli M, Sglavo G, Pastore G, Cavallaro A, D'Armiento, Salvatore M, Nappi C
* The Role Of Mri In The Clinical Management Of Foetuses With Central Nervous System Abnormalities In A Tertiary Referral Center (298 views)
Ultrasound Obstet Gynecol John Wiley And Sons Ltd, 2013 Nov 1; N/D: 1002/uog-1002/uog.
Impact Factor: 5.694
View Export to BibTeX Export to EndNote
Marciano C, Galderisi M, Gargiulo P, Acampa W, D'Amore C, Esposito R, Capasso E, Savarese G, Casaretti L, Lo Iudice F, Esposito G, Rengo G, Leosco D, Cuocolo A, Perrone-Filardi P
* Effects of type 2 diabetes mellitus on coronary microvascular function and myocardial perfusion in patients without obstructive coronary artery disease (917 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2012 Jul; 39(7): 1199-1206.
Impact Factor: 5.114
View Export to BibTeX Export to EndNote
Striano P, Caranci F, Pappata S, Zara F, Striano S
* Hemidystonia in uncontrolled type 2 diabetes mellitus (291 views)
Arch Neurol (ISSN: 1538-3687electronic, 0003-9942linking), 2011 May; 68(5): 674-675.
Impact Factor: 7.584
View Export to BibTeX Export to EndNote
Bozzetto L, Prinster A, Mancini M, Giacco R, De Natale C, Salvatore M, Riccardi G, Rivellese AA, Annuzzi G
* Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution (461 views)
Eur J Clin Invest (ISSN: 0014-2972, 1365-2362, 0014-2972linking), 2011 Jan; 41(1): 39-44.
Impact Factor: 3.018
View Export to BibTeX Export to EndNote
Storto G, Pellegrino T, Sorrentino AR, Luongo L, Petretta M, Cuocolo A
* Estimation of coronary flow reserve by sestamibi imaging in type 2 diabetic patients with normal coronary arteries (398 views)
J Nucl Cardiol (ISSN: 1532-6551, 1071-3581, 1532-6551electronic), 2007 Apr; 14(2): 194-199.
Impact Factor: 2.359
View Export to BibTeX Export to EndNote
* Abnormal 1-hour post-load glycemia during pregnancy impairs post-partum metabolic status: a single-center experience (171 views)
J Endocrinol Invest (ISSN: 1720-8386, 0391-4097, 1720-8386electronic), 2017 Oct 24; N/D: N/D-N/D.
Impact Factor: 3.166
View Export to BibTeX Export to EndNote
Monti SM, Supuran CT, De Simone G
* DPP-4 inhibitors: a patent review (2012 - 2014) (574 views)
Expert Opin Ther Pat (ISSN: 1354-3776, 1744-7674electronic), 2015 Feb; 25(2): 209-236.
Impact Factor: 4.626
View Export to BibTeX Export to EndNote
Coppo C, Bonfanti D, Bo S, Giordanino C, Gallo M, Cococcia S, Ciccone G, Smedile A, Ciancio A, Bugianesi E, Fagoonee S, Pellicano R, Rizzetto M, Saracco GM
* Risk of microangiopathy in type 2 diabetes mellitus patients with or without chronic hepatitis C: Results of a retrospective long-term controlled cohort study (303 views)
Dig Liver Dis (ISSN: 1590-8658, 1590-8658linking), 2015; 47(5): 405-410.
Impact Factor: 2.719
View Export to BibTeX Export to EndNote
Paladini D, Quarantelli M, Sglavo G, Pastore G, Cavallaro A, D'Armiento MR, Salvatore M, Nappi C
* Accuracy of neurosonography and MRI in clinical management of fetuses referred with central nervous system abnormalities (342 views)
Ultrasound Obst Gyn (ISSN: 0960-7692, 1469-0705), 2014 Aug; 44(2): 188-196.
Impact Factor: 3.853
View Export to BibTeX Export to EndNote
Paladini D, Quarantelli M, Sglavo G, Pastore G, Cavallaro A, D'Armiento, Salvatore M, Nappi C
* The Role Of Mri In The Clinical Management Of Foetuses With Central Nervous System Abnormalities In A Tertiary Referral Center (298 views)
Ultrasound Obstet Gynecol John Wiley And Sons Ltd, 2013 Nov 1; N/D: 1002/uog-1002/uog.
Impact Factor: 5.694
View Export to BibTeX Export to EndNote
Marciano C, Galderisi M, Gargiulo P, Acampa W, D'Amore C, Esposito R, Capasso E, Savarese G, Casaretti L, Lo Iudice F, Esposito G, Rengo G, Leosco D, Cuocolo A, Perrone-Filardi P
* Effects of type 2 diabetes mellitus on coronary microvascular function and myocardial perfusion in patients without obstructive coronary artery disease (917 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2012 Jul; 39(7): 1199-1206.
Impact Factor: 5.114
View Export to BibTeX Export to EndNote
Striano P, Caranci F, Pappata S, Zara F, Striano S
* Hemidystonia in uncontrolled type 2 diabetes mellitus (291 views)
Arch Neurol (ISSN: 1538-3687electronic, 0003-9942linking), 2011 May; 68(5): 674-675.
Impact Factor: 7.584
View Export to BibTeX Export to EndNote
Bozzetto L, Prinster A, Mancini M, Giacco R, De Natale C, Salvatore M, Riccardi G, Rivellese AA, Annuzzi G
* Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution (461 views)
Eur J Clin Invest (ISSN: 0014-2972, 1365-2362, 0014-2972linking), 2011 Jan; 41(1): 39-44.
Impact Factor: 3.018
View Export to BibTeX Export to EndNote
Storto G, Pellegrino T, Sorrentino AR, Luongo L, Petretta M, Cuocolo A
* Estimation of coronary flow reserve by sestamibi imaging in type 2 diabetic patients with normal coronary arteries (398 views)
J Nucl Cardiol (ISSN: 1532-6551, 1071-3581, 1532-6551electronic), 2007 Apr; 14(2): 194-199.
Impact Factor: 2.359
View Export to BibTeX Export to EndNote
9 Records (7 excluding Abstracts).
Total impact factor: 38.133 (29.72 excluding Abstracts).
Total 5 year impact factor: 35.685 (26.337 excluding Abstracts).
Total impact factor: 38.133 (29.72 excluding Abstracts).
Total 5 year impact factor: 35.685 (26.337 excluding Abstracts).
256 views. Last view on Sunday 21 May 2023, 13:13:57
ibb.cnr.it
